AIMP2 and LMO3

  • Number of citations of the paper that reports this interaction (PMID 16189514)
  • 699

AIMP2

LMO3

Gene Name aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 LIM domain only 3 (rhombotin-like 2)
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 48 interactors: ACTB AIMP1 APP BCAS2 BLOC1S4 BYSL C19orf57 CEP170P1 CHD3 DARS DARS2 DEAF1 DSN1 EPRS EPS8 FGB FHL3 FUBP1 GYS1 ICE1 KARS KDR KIAA1377 KLC2 LMO2 LMO3 LNX1 LUC7L2 MATR3 MCF2L MIS18A NDEL1 NECAB2 NGFRAP1 PARK2 PCMT1 PLEKHF2 PPP2R1A PRKAA2 PSME1 TANK TERF2IP TFIP11 TP53 TRAF2 TRMT2A ZC3H12A ZGPAT 33 interactors: AIMP2 BANP CARF CCDC33 CCDC85B CEP170P1 CEP57L1 FAM131C FBLIM1 FOS GABPB1 HNRNPC HNRNPM IKZF1 KCTD1 KXD1 LDB1 LDB2 MBIP MDFI NBPF22P NHLH2 NUTM1 PHC2 RALYL RFX6 RORA SAMD3 SP4 SPERT TAX1BP1 ZBTB43 ZBTB8A
Entrez ID 7965 55885
HPRD ID 02915 11832
Ensembl ID ENSG00000106305 ENSG00000048540
Uniprot IDs A8MU58 Q13155 Q8TAP4 Q9NYC6
PDB IDs 4DPG
Enriched GO Terms of Interacting Partners?
Tagcloud ?
4x20  abl  abrogated  bbb  c57  compacts  dopaminergic  e3  easily  endothelium  inno  irreversible  microvessel  mitigated  mptp  nanomolar  neurodegeneration  neuroprotective  nigra  nitrative  parkin  pars  pd  pharmacokinetic  striatum  substantia  th  translated  ubiquitously 
aggressive  aggressiveness  atypical  benign  biosignatures  clinically  constitute  decisions  demand  forty  fourteen  histologically  igf1r  meningioma  meningiomas  metabolic  mostly  nmr  oligonucleotide  otherwise  predominant  proceeds  profiles  recur  recurrence  relevance  subgroup  subgroups  turnover 
Tagcloud (Difference) ?
4x20  abl  abrogated  bbb  c57  compacts  dopaminergic  e3  easily  endothelium  inno  irreversible  microvessel  mitigated  mptp  nanomolar  neurodegeneration  neuroprotective  nigra  nitrative  parkin  pars  pd  pharmacokinetic  striatum  substantia  th  translated  ubiquitously 
aggressive  aggressiveness  atypical  benign  biosignatures  clinically  constitute  decisions  demand  forty  fourteen  histologically  igf1r  meningioma  meningiomas  metabolic  mostly  nmr  oligonucleotide  otherwise  predominant  proceeds  profiles  recur  recurrence  relevance  subgroup  subgroups  turnover 
Tagcloud (Intersection) ?